The overwhelming majority of those in New York City who obtained a naloxone kit to counteract opioid overdose had a high need for the drug, according to a new study by Weill Cornell Medicine investigators.
New Cornell research shows that individuals of East Asian ancestry have greater risk of elevated iron stores than people of Northern European ancestry, putting them at higher risk of chronic conditions such as heart disease, Type 2 diabetes, liver disease and cancer.
Women who go on to develop postpartum depression may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood during the third trimester of pregnancy.
Dr. Jim Castellanos, Ph.D. ’18, M.D. ’20, an instructor in anesthesiology at Weill Cornell Medicine, has been selected as a 2024 Hanna H. Gray Fellow by the Howard Hughes Medical Institute.
A group of 34 earned their short white coats as the newest class in Weill Cornell Medicine’s Master of Science in Health Sciences for Physician Assistants program.
Weill Cornell Medicine has received a five-year, $2.3 million grant from the Centers for Disease Control and Prevention to improve equitable access to care, quality of life and survival outcomes for young people with all stages of breast cancer.
Weill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears to reduce anxiety without side effects.
The White House has recognized six Cornell faculty members, three from the Ithaca campus and three from Weill Cornell Medicine, with 2025 Presidential Early Career Awards for Scientists and Engineers. The awards were announced Jan. 14.